Welcome to The Weekly Skin Scan where our editors will keep you up-to-date on the latest news and research that could impact your practice. Browse more stories here.
A 40mg doxycycline dose with a topical containing adapalene 0.3% and benzoyl peroxide 2.5% is an effective and safe treatment option for severe acne, according to a single-center pilot study published recently.
Topical ivermectin cream, 1% (Soolantra, Galderma) represents an advance in treatment for rosacea, offering superior efficacy and tolerability compared with previously available therapies, says Jeffrey S. Fromowitz, M.D., who spoke at the Orlando Dermatology Aesthetic & Clinical Conference.
Switching patients with moderate-to-severe plaque psoriasis from one biologic to another is a multifactorial decision and may depend on safety, efficacy or dosing intervals. Ron Vender, M.D., offers insight into how to switch appropriately.
A phase 2 study shows that the oral Janus kinase (JAK) 1 inhibitor abrocitinib quickly improved atopic dermatitis (AD) severity and symptoms versus placebo with some measures achieving statistically significant separation in days.
Stem cell factor, a growth factor critical for melanocyte survival, may play an important role in the development of benign and malignant skin hyperpigmentation disorders.
In this Dermatology Times® podcast, Jonathan Silverberg, MD, PhD, MPH, discusses trends and geographic distribution of the condition's prevalence, realistic expectations for persistence beyond childhood, and effective differential diagnosis for adult patients.
Listen to the podcast now.
Listen to the podcast now.